Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma

Exp Mol Pathol. 2014 Aug;97(1):57-65. doi: 10.1016/j.yexmp.2014.05.005. Epub 2014 May 16.

Abstract

The diagnosis of bone marrow (BM) infiltration by Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) poses a diagnostic challenge in hematopathology. No definitive morphology or immunophenotype is able to distinguish between infiltration of paraffin-embedded BM sections by WM/LPL and other indolent lymphomas, in particular those of the splenic marginal zone (SMZL) which may also show plasmacytic maturation. An oncogenic gain-of-function mutation (L265P) in the human MYD88 gene has been found to be present in most cases of WM/LPL, yet is absent in most other cases of B-cell chronic lymphoproliferative disorders (LPD), including SMZL. Here, we compare two newly developed diagnostic protocols for detection of this mutation in paraffin-embedded archival tissues which are particularly applicable to decalcified BM biopsies. Sanger sequencing can easily detect levels of BM infiltration above 15% by WM lymphoplasmacytic cells, while the allele-specific PCR can detect the L265P mutation in BM infiltrations below 1% of lymphoma cells. We show that these methods are easily applicable to archival BM specimens and markedly improve diagnostic accuracy of BM infiltrations by indolent B-cell lymphomas.

Keywords: Bone marrow; Infiltration; Lymphoplasmacytic lymphoma; MYD88; Molecular diagnosis; Waldenström macroglobulinemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Biopsy
  • Bone Marrow / pathology
  • Case-Control Studies
  • DNA Mutational Analysis / methods*
  • Formaldehyde
  • Humans
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / pathology
  • Molecular Sequence Data
  • Mutation
  • Myeloid Differentiation Factor 88 / genetics*
  • Paraffin Embedding
  • Polymerase Chain Reaction / methods
  • Reproducibility of Results
  • Waldenstrom Macroglobulinemia / genetics*

Substances

  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • Formaldehyde